As of 2026-03-27, the Relative Valuation of Iovance Biotherapeutics Inc (IOVA) is (15.55) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.75 USD, the upside of Iovance Biotherapeutics Inc based on Relative Valuation is -514.6%.
The range of the Relative Valuation is (15.65) - (15.97) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 22.9x - 25.6x | 24.2x |
| Forward P/E multiples | 20.2x - 23.4x | 21.4x |
| Fair Price | (15.65) - (15.97) | (15.55) |
| Upside | -517.2% - -526.0% | -514.6% |
| Date | P/E |
| 2026-03-24 | -5.30 |
| 2026-03-23 | -5.32 |
| 2026-03-20 | -5.41 |
| 2026-03-19 | -5.67 |
| 2026-03-18 | -5.52 |
| 2026-03-17 | -5.70 |
| 2026-03-16 | -5.92 |
| 2026-03-13 | -5.80 |
| 2026-03-12 | -5.96 |
| 2026-03-11 | -7.09 |
| 2026-03-10 | -7.62 |
| 2026-03-09 | -7.92 |
| 2026-03-06 | -7.51 |
| 2026-03-05 | -6.71 |
| 2026-03-04 | -6.24 |
| 2026-03-03 | -5.49 |
| 2026-03-02 | -5.55 |
| 2026-02-27 | -5.65 |
| 2026-02-26 | -5.55 |
| 2026-02-25 | -5.61 |
| 2026-02-24 | -5.54 |
| 2026-02-23 | -4.23 |
| 2026-02-20 | -4.20 |
| 2026-02-19 | -4.17 |
| 2026-02-18 | -3.98 |
| 2026-02-17 | -3.84 |
| 2026-02-13 | -3.76 |
| 2026-02-12 | -3.69 |
| 2026-02-11 | -3.81 |
| 2026-02-10 | -3.81 |
| 2026-02-09 | -3.81 |
| 2026-02-06 | -3.71 |
| 2026-02-05 | -3.46 |
| 2026-02-04 | -3.57 |
| 2026-02-03 | -3.87 |
| 2026-02-02 | -3.82 |
| 2026-01-30 | -3.74 |
| 2026-01-29 | -3.85 |
| 2026-01-28 | -4.03 |
| 2026-01-27 | -4.37 |
| 2026-01-26 | -4.23 |
| 2026-01-23 | -3.87 |
| 2026-01-22 | -3.94 |
| 2026-01-21 | -3.68 |
| 2026-01-20 | -3.57 |
| 2026-01-16 | -3.46 |
| 2026-01-15 | -3.25 |
| 2026-01-14 | -3.49 |
| 2026-01-13 | -3.44 |
| 2026-01-12 | -3.52 |